tiprankstipranks
Unitedhealth Group Inc. (UNH)
NYSE:UNH
US Market
Want to see UNH full AI Analyst Report?

UnitedHealth (UNH) Earnings Dates, Call Summary & Reports

23,780 Followers

Earnings Data

Report Date
Jul 10, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
4.85
Last Year’s EPS
4.08
Same Quarter Last Year
Moderate Buy
Based on 23 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 21, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call portrayed a generally constructive and improving operational picture: the company delivered an earnings beat, modest revenue growth, improved medical care ratio, strong cash generation and clear early progress at Optum Health and Optum Rx driven by operational improvements and digital/AI initiatives. Management emphasized disciplined pricing, continued investments in AI (nearly $1.5B in 2026) and capital returns, while acknowledging known challenges such as membership contraction (including a large ACA decline), Medicaid funding pressure, persistently elevated medical trends, one-time seasonal and prior-year tailwinds, and regulatory uncertainties that could temper future performance. Overall, leadership signaled cautious optimism with continued focus on execution and margin recovery, but noted that meaningful second-quarter data and the back-half seasonality will be important to confirm sustainability.
Company Guidance
UnitedHealth refreshed its full‑year outlook to greater than $18.25 GAAP‑adjusted EPS after a strong Q1 that produced $7.23 of adjusted EPS on $111.7 billion of revenue (up 2% YoY), $8.9 billion of operating cash flow (1.4x net income), and 49.1 million domestic members (down from 49.8M at year‑end 2025); Q1 medical care ratio was 83.9% (vs. 84.8% a year ago) and the operating cost ratio was 13.8% (Q1 included ~$900M of incentive comp vs. $35M in Q1‑2025). Management expects roughly two‑thirds of 2026 earnings in H1 (UnitedHealthcare >75% H1‑weighted; Optum Health and UHC earnings concentrated in H1; Optum Insight and Optum Rx ~60% of earnings in H2), a Medicare membership contraction of about 1.3M and ACA membership to fall ~1/3 in 2026, and reiterated targets including Optum Health long‑term margins of 6–8%, a year‑ahead AI investment plan of nearly $1.5B, at least $2B of share repurchases by end‑Q2, a debt‑to‑capital ratio at 42.9% with a year‑end goal of 40%, prior‑year development tailwinds of a little north of $500M in Q1, and operational goals (reduce medical prior authorizations 30%+, 95% of PAs electronic, ~50% processed real‑time, >90% approved within 1 business day) alongside digital adoption metrics (≈50% of members registered, 73M digital visits in Q1, >80% of consumer contacts digital, provider transactions +75% YoY, ~75% of in‑network providers on portal/APIs).
Adjusted EPS Beat
Reported adjusted earnings per share of $7.23 in Q1, materially ahead of expectations and supporting an updated full-year outlook of greater than $18.25 per share.
Revenue Growth and Strong Cash Flow
Total revenues of $111.7 billion, up 2% year-over-year, with operating cash flow of $8.9 billion in the quarter (1.4x net income).
Improved Medical Care Ratio
Reported medical care ratio improved to 83.9% from 84.8% in Q1 2025 (about 90 basis points improvement), driven by pricing discipline, medical cost management and favorable reserve development.
Optum Health Operational Turnaround
Optum Health adjusted earnings of $1.3 billion reflecting pricing and operational improvements; examples include a ~35% reduction in skilled nursing facility admissions (in the initial month in one region), clinical reviews up >50% and a 12% YoY increase in patient-facing hours.
Digital Adoption and Prior Authorization Automation
Almost 50% of members registered for UHC digital access; 73 million digital visits in Q1 (up 42% over two years); >80% of consumer contacts are digital. Prior authorization progress: ~95% of requests submitted electronically, ~50% processed in real time and >90% approved on average within 1 business day.
Optum Rx Client Wins and Efficiency Gains
Onboarded more than 800 new Optum Rx clients to start the year; contact center volume down 25% via digital/AI self-service with member satisfaction over 95%. PreCheck PA reduced prescription approval time from >8 hours to <30 seconds and cut denials for missing information by 68% and appeals by 88%.
Material AI Investment with Early Traction
Plan to invest nearly $1.5 billion in AI-related initiatives in 2026; Optum Insight/AI products showing traction (Optum Real 0.5 billion YTD transactions, targeting >2.5 billion by year-end) and expected conservative 2:1 return on many programs over next few years.
Capital Allocation & Balance Sheet Progress
Debt-to-capital ratio improved to 42.9% (on track to 40% year-end target). Initiated share repurchases earlier than planned with at least $2 billion expected to be deployed by end of Q2 and continued discipline on M&A and strategic capital deployment.

UnitedHealth (UNH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

UNH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 10, 2026
2026 (Q2)
4.85 / -
4.08
Apr 21, 2026
2026 (Q1)
6.58 / 7.23
7.20.42% (+0.03)
Jan 27, 2026
2025 (Q4)
2.10 / 2.11
6.81-69.02% (-4.70)
Oct 28, 2025
2025 (Q3)
2.79 / 2.92
7.15-59.16% (-4.23)
Jul 29, 2025
2025 (Q2)
4.45 / 4.08
6.8-40.00% (-2.72)
Apr 17, 2025
2025 (Q1)
7.29 / 7.20
6.914.20% (+0.29)
Jan 16, 2025
2024 (Q4)
6.74 / 6.81
6.1610.55% (+0.65)
Oct 15, 2024
2024 (Q3)
7.00 / 7.15
6.568.99% (+0.59)
Jul 16, 2024
2024 (Q2)
6.65 / 6.80
6.1410.75% (+0.66)
Apr 16, 2024
2024 (Q1)
6.61 / 6.91
6.2610.38% (+0.65)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

UNH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 21, 2026
$323.48$346.01+6.96%
Jan 27, 2026
$348.93$280.52-19.61%
Oct 28, 2025
$360.73$362.56+0.51%
Jul 29, 2025
$276.33$255.71-7.46%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Unitedhealth Group Inc. (UNH) report earnings?
Unitedhealth Group Inc. (UNH) is schdueled to report earning on Jul 10, 2026, Before Open (Confirmed).
    What is Unitedhealth Group Inc. (UNH) earnings time?
    Unitedhealth Group Inc. (UNH) earnings time is at Jul 10, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is UNH EPS forecast?
          UNH EPS forecast for the fiscal quarter 2026 (Q2) is 4.85.

            UnitedHealth (UNH) Earnings News

            UNH Earnings: UnitedHealth Stock Drops as Medicare Pricing Overshadows Revenue Growth
            Premium
            Market News
            UNH Earnings: UnitedHealth Stock Drops as Medicare Pricing Overshadows Revenue Growth
            3M ago
            Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
            Premium
            Market News
            Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
            3M ago
            UNH Earnings: UnitedHealth Stock Pops on Q3 Earnings Beat and Raised Guidance
            Premium
            Market News
            UNH Earnings: UnitedHealth Stock Pops on Q3 Earnings Beat and Raised Guidance
            6M ago
            UnitedHealth (UNH) Is About to Report Q3 Earnings Today. Here Is What to Expect
            Premium
            Market News
            UnitedHealth (UNH) Is About to Report Q3 Earnings Today. Here Is What to Expect
            6M ago